首页 | 【重要提示】 | 期刊简介 | 编委会 | 在线投稿 | 期刊稿约 | 联系我们

崔海燕,胡媛媛,马俊,肖和平,吴福蓉.轻型脊柱结核药物治疗149例临床分析[J].脊柱外科杂志,2018,16(4):218-221,226.
轻型脊柱结核药物治疗149例临床分析     点此下载全文 (Fulltext)
崔海燕  胡媛媛  马俊  肖和平  吴福蓉
同济大学附属上海市肺科医院结核病临床研究中心, 上海市结核病(肺)
重点实验室, 上海 200433
基金项目:
DOI:10.3969/j.issn.1672-2957.2018.04.006
摘要点击次数: 164
全文下载次数: 176
摘要:
      目的 评价药物治疗早期轻型脊柱结核的临床疗效,为完善轻型脊柱结核诊断标准及制定抗结核治疗方案奠定基础。方法 回顾性分析2012年1月-2013年12月收治的早期诊断为轻型脊柱结核的149例患者临床资料。所有患者均接受异烟肼(H)、利福平(R)、乙胺丁醇(E)、吡嗪酰胺(Z)、左氧氟沙星(L)方案(6HREZL/6HREZ)抗结核治疗,辅以营养支持并完成2年随访。治疗期间每个月监测肝肾功能、红细胞沉降率(ESR)、C反应蛋白(CRP),治疗开始每隔3个月行影像学检查。随访期间根据临床治愈标准评价疗效,并分析治疗前后患者临床症状、疼痛视觉模拟量表(VAS)评分、病变愈合、ESR、CRP及药物不良反应发生情况及影像学检查变化。结果 138例经药物治疗获得临床治愈,11例在3个月内接受手术治疗。2年随访期间,所有患者疼痛缓解,恢复正常的日常活动,无神经功能障碍,骨质愈合,椎旁脓肿吸收;ESR及CRP恢复正常;抗结核药物不良反应轻微。结论 6HREZL/6HREZ方案治疗早期轻型脊柱结核疗效显著,抗结核药物治疗方案不良反应轻微,安全有效。
关键词:结核,脊柱  抗结核药  药物疗法
Clinical study of drug therapy in 149 patients with mild spinal tuberculosis    Fulltext
CUI Hai-yan  HU Yuan-yuan  MA Jun  XIAO He-ping  WU Fu-rong
Shanghai Key Lab of Tuberculosis, Clinic and Research Center of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China
Fund Project:
Abstract:
      Objective To evaluate the outcomes of early diagnosed mild spinal tuberculosis after improved chemotherapy regimen treatment,and to lay a foundation for the diagnosis and chemotherapy of mild spinal tuberculosis. Methods The clinical data of 149 mild spinal tuberculosis patients from January 2012 to December 2013 were retrospectively analyzed. Patients were treated by improved anti-tuberculosis chemotherapy(isoniazide,rifampin,ethambutol,pyrazinamide and levofloxacin)regimens for 12 months(6HREZL/6HREZ) and followed up for at least 2 years upon the completion of treatment. Liver and kidney function,erythrocyte sedimentation rate(ESR) and C-reactive protein(CRP) were monitored every month during treatment. The imaging examination was performed every 3 months after the treatment began. The curative effect was evaluated according to the clinical cure criteria during the follow-up period,and the clinical symptoms,pain visual analogue scale(VAS) score,lesion healing,ESR,CRP,adverse drug reaction and imaging changes were analyzed before and after the treatment. Results Of the 149 cases,138 cases were cured after drug treatment,and 11 cases received surgical treatment within 3 months. During the 2-year follow-up period,all patients were relieved of pain;resumed normal daily activities,no neurological dysfunction,bone healing,paravertebral abscess absorption;ESR and CRP were restored to normal;adverse reactions of anti-tuberculosis drugs were slight and reversible. Conclusion The 6HREZL/6HREZ regimen is effective in the treatment of early diagnosed light spinal tuberculosis. The anti-tuberculosis treatment regimen is safe and effective with mild adverse effects.
Keywords:Tuberculosis,spinal  Antitubercular agents  Drug therapy
HTML   在线阅读   查看全文  查看/发表评论  下载PDF阅读器

您是第1484893位访问者

版权所有 © 脊柱外科杂志    沪ICP备07510177号-8

地址:上海市成都北路500号峻岭广场 电子信箱:spinejournal@163.com
邮政编码:200003 电话:021-33300675,021-63609919转8537或8855 传真:

本系统由北京勤云科技发展有限公司设计